| Trustees: | Mr S R Cannon MBE, MCh, FRCS |
|---|---|
| Mr D I S Sweetnam FRCS | |
| Mr J L Williams, CBE, FRCS, FDSRCS | |
| Mr M J W Rushton | |
| Administrator: | Ben Haines |
| Banker: | CAF Bank Ltd |
| Kings Hill | |
| West Malling | |
| Kent | |
| ME19 4JQ | |
| Auditor: | MHA Monahans |
| Fortescue House | |
| Court Street | |
| Trowbridge | |
| Wiltshire | |
| BA14 8FA | |
| Investment Manager: | Sarasin & Partners LLP |
| Juxon House | |
| 100 St Paul's Churchyard | |
| London | |
| EC4M 8BU | |
| Custodian Trustee: | The Bank of New York Europe Limited |
| 2021 | 2020 | ||
|---|---|---|---|
| Number of awards granted | Note 6 | 10 | 6 |
| Total awards | Note 6 | 529,781 | £466,626 |
| Total investment value | Note 9 | 17,319,378 | £14,524,122 |
13 January 2022
24 January 2022
| Unrestricted | Expendable | Unrestricted | Expendable | ||||
|---|---|---|---|---|---|---|---|
| Distribution | Endowment | Total | Distribution | Endowment | Total | ||
| Fund | Fund | Fund | Fund | ||||
| 2021 | 2021 | 2021 | 2020 | 2020 | 2020 | ||
| £ | £ | £ | £ | £ | £ | ||
| Income from: | |||||||
| Investments | 2 | 616,513 | 616,513 | 612,188 | 612,188 | ||
| Other | 2 | 227 | 227 | 4,578 | 4,578 | ||
| Total | 616,740 | 616,740 | 616,766 | 616,766 | |||
| Expenditure on: | |||||||
| Raising funds | 3 | 78,025 | 78,025 | 75,811 | 75,811 | ||
| Charitable activities | 4 | 568,348 | 568,348 | 508,086 | 508,086 | ||
| Total | 568,348 | 78,025 | 646,373 | 508,086 | 75,811 | 583,897 | |
| Net income/ | |||||||
| (expenditure) before | 48,392 | (78,025) | (29,633) | 108,680 | (75,811) | 32,869 | |
| gains/(losses) | |||||||
| Net gains/(losses) on investments |
2,913,599 | 2,913,599 | (759,897) | (759,897) | |||
| Net income/ | |||||||
| (expenditure) and net | 13 | 48,392 | 2,835,574 | 2,883,966 | 108,680 | (835,708) | (727,028) |
| movement in funds | |||||||
| Reconciliation of | |||||||
| funds: | |||||||
| Total funds brought forward |
13 | 1,077,972 | 13,245,804 | 14,323,776 | 969,292 | 14,081,512 | 15,050,804 |
| Total funds carried forward |
13 | 1,126,364 | 16,081,378 | 17,207,742 | 1,077,972 | 13,245,804 | 14,323,776 |
13 January 2022
2021 |
2020 |
||
|---|---|---|---|
| Notes | £ | £ | |
| Cash flow from operating activities: | |||
| Net cash used in operating activities | 16 |
(788,985) | (257,398) |
| Net cash used in operating activities | (788,985) | (257,398) | |
| Cash flows from investing activities: | |||
| Dividends, interest and rents from investments | 616,740 | 616,766 | |
| Proceeds from sale of investments | 576,000 | ||
| Purchase of investments | (457,657) | (774,041) | |
| Net cash provided by investing activities | 735,083 | (157,275) | |
| Change in cash and cash equivalents in the year | (53,902) | (414,673) | |
| Cash and cash equivalents at the beginning of the | 134,569 | 549,242 | |
| reporting period | |||
| Cash and cash equivalents at the end of the reporting | 80,667 | 134,569 | |
| period |
| Unrestricted Distribution Fund |
Total 2021 |
Un restricted Distribution Fund |
Total 2020 |
||
|---|---|---|---|---|---|
| £ | £ | £ | £ | ||
| Dividends received | 616,513 | 616,513 | 612,188 | 612,188 | |
| Interest received | 227 | 227 | 4,517 | 4,517 | |
| Other investment income | 61 | 61 | |||
| 616,740 | 616,740 | 616,766 | 616,766 |
| Expendable Endowment Fund |
Total2021 |
Expendable Endowment Fund |
Total2020 |
|
|---|---|---|---|---|
| £ | £ | £ | £ | |
| Investment managementfees | 77,922 | 77,922 | 75,717 | 75,717 |
| Bank charges | 103 | 103 | 94 | 94 |
| 78,025 | 78,025 | 75,811 | 75,811 |
| Grants to | Support | Total | Grants to | Support | Total | |
|---|---|---|---|---|---|---|
| institutions | costs | 2021 |
institutions | costs | 2020 |
|
| £ | £ | £ | £ | £ | £ | |
| Funded from unrestricted | 529,781 | 38,567 | 568,348 | 466,626 | 41,460 | 508,086 |
| distribution fund | ||||||
| 529,781 | 38,567 | 568,348 | 466,626 | 41,460 | 508,086 |
| Other support costs |
Governance costs |
Total allocated 2021 |
Other support costs |
Governance costs |
Total allocated 2020 |
|
|---|---|---|---|---|---|---|
| £ | £ | £ | £ | £ | £ | |
| Accountancy | 16,216 | 16,216 | 32,432 | 15,900 | 15,900 | 31,800 |
| Audit fees | 6,135 | 6,135 | 5,880 | 5,880 | ||
| Other costs | 3,780 | 3,780 | ||||
| 16,216 | 22,351 | 38,567 | 15,900 | 25,560 | 41,460 |
| 6 | Analysis of grants payable | |||||
|---|---|---|---|---|---|---|
| Other | Buildings | |||||
| Research | charitable | and | Total | Total | ||
| costs | endeavours | equipment | 2021 | 2020 | ||
| £ | £ | £ | £ | £ | ||
| Reconciliation of grants payable: | ||||||
| Commitments at 1 April | 331,181 | 331,181 | ||||
| Commitments made during the year: | ||||||
| Antibiotic Research UK | 15,000 | 15,000 | 15,000 | |||
| Bloodwise | 10,000 | |||||
| University of Cambridge | 264,000 | 264,000 | 235,000 | |||
| King's College London | 110,521 | |||||
| The Royal Marsden Cancer Charity | 92,105 | |||||
| The Row UK Foundation | 4,000 | |||||
| Royal College ofSurgeons | 75,000 | 75,000 | ||||
| Royal College ofAnaesthetists | 53,220 | 53,220 | ||||
| Northamptonshire Rape Crisis | 10,000 | 10,000 | ||||
| INSPIRE Foundation | 22,252 | 22,252 | ||||
| Stroke Association | 38,309 | 38,309 | ||||
| The Royal Hospital for Neuro Disability | 30,000 | 30,000 | ||||
| DKMS (Delete Blood Cancer) | 2,000 | 2,000 | ||||
| Care for Veterens | 20,000 | 20,000 | ||||
| Total commitments made in year | 499,781 | 30,000 | 529,781 | 466,626 | ||
| Total commitments made | 830,962 | 30,000 | 860,962 | 466,626 | ||
| Grants paid during the year | (645,846) | (30,000) | (675,846) | (135,445) | ||
| Commitments at 31 March | 185,116 | 185,116 | 331,181 |
2021 |
2020 |
|
|---|---|---|
| £ | £ | |
| Within one year | 91,116 | 146,065 |
| Between two and five years | 94,000 | 185,116 |
| 185,116 | 331,181 |
| This is stated after charging: | ||
|---|---|---|
2021 |
2020 |
|
| £ | £ | |
| Auditors' remuneration | 6,135 | 5,880 |
| Investments | ||
2021 |
2020 |
|
| £ | £ | |
| Marketvalue at 1 April | 14,524,122 | 14,509,978 |
| Acquisitions at cost | 457,657 | 774,041 |
| Disposal proceeds | (576,000) | |
| Net realised and unrealised gains/(losses) in the | 2,913,599 | (759,857) |
| year | ||
| Marketvalue at 31 March | 17,319,378 | 14,524,122 |
| Historic costvalue at end ofyear | 13,111,085 | 13,210,455 |
| Level 1 | Total | |
|---|---|---|
| £ | £ | |
| Investments listed on stock exchange | 17,243,664 | 17,243,664 |
| Cash held in the portfolio | 75,714 | 75,714 |
| 17,319,378 | 17,319,378 | |
| The analysis at 31 March 2020was as follows: | ||
| Level 1 | Total | |
| £ | £ | |
| Investments listed on stock exchange | 14,478,350 | 14,478,350 |
| Cash held in the portfolio | 45,772 | 45,772 |
| 14,524, 122 | 14,524,122 | |
| Investment risks |
| INVESTMENTS | 2021 | 2020 | Direct | Indirect | |
|---|---|---|---|---|---|
| £ | £ | ||||
| Fixed Income | 2,621,746 | 2,655,934 | Credit | Other, | Interest |
| UK Equities | 11,788,785 | 2,414,618 | Credit | Other | |
| Global Equities | - | 6,694,978 | Credit | Other, | Currency |
| Property | 386,552 | 427,147 | Credit | Other | |
| Alternative Investments | 1,384,429 | 1,393,666 | Credit | Other | |
| Liquid Assets | 1,205,095 | 937,779 | Credit | Interest |
| 2021 | 2020 | |
|---|---|---|
| £ | £ | |
| Accrued income | 31,937 | 27,255 |
| 31,937 | 27,255 | |
| Creditors | ||
| 2021 | 2020 | |
| Amounts falling due within one year: | £ | £ |
| Accruals | 39,124 | 30,989 |
| Grants payable (note 6) | 91,116 | 146,065 |
| 130,240 | 177,054 | |
| Amounts falling due after one year: | ||
| Grants payable (note 6) | 94,000 | 185,116 |
| Total creditors | 224,240 | 362,170 |
| Financial instruments | ||
| 2021 | 2020 | |
| £ | £ | |
| Financial assets measured at fair value through statement of | 17,319,378 | 14,524,122 |
| financial activities (note 9) |
| Balance b/fwd 2021 |
Income2021 |
Expenditure2021 |
Gains2021 |
Balance c/fwd 2021 |
|
|---|---|---|---|---|---|
| £ | £ | £ | £ | £ | |
| Expendable endowment funds | |||||
| Expendable endowmentfunds | 13,245,804 | (78,025) | 2,913,599 | 16,081,378 | |
| Total expendable endowment funds | 13,245,804 | (78,025) | 2,913,599 | 16,081,378 | |
| Unrestricted distribution funds | |||||
| Unrestricted distribution funds | 1,077,972 | 616,740 | (568,348) | 1,126,364 | |
| Total unrestricted distribution funds | 1,077,972 | 616,740 | (568,348) | 1,126,364 | |
| Total funds | 14,323,776 | 616,740 | (646,373) | 2,913,599 | 17,207,742 |
| Balance b/fwd 2020 |
Income2020 |
Expenditure2020 |
Losses2020 |
Balance c/fwd 2020 |
|
| £ | £ | £ | £ | £ | |
| Expendable endowment funds | |||||
| Expendable endowmentfunds | 14,081,512 | (75,811) | (759,897) | 13,245,804 | |
| Total expendable endowment funds | 14,081,512 | (75,811) | (759,897) | 13,245,804 | |
| Unrestricted distribution funds | |||||
| Unrestricted distribution funds | 969,292 | 616,766 | (508,086) | 1,077,972 | |
| Total unrestricted distribution funds | 969,292 | 616,766 | (508,086) | 1,077,972 | |
| Total funds | 15,050,804 | 616,766 | (583,897) | (759,897) | 14,323,776 |
| Net current | ||||||
|---|---|---|---|---|---|---|
| assets/ | Non-current | |||||
| Fixed assets | (liabilities) | liabilities | Total | |||
2021 |
2021 |
2021 |
2021 |
|||
| £ | £ | £ | £ | |||
| Expendable | endowment | funds | 16,407,731 | (326,353) | - | 16,081,378 |
| Unrestricted | distribution | funds | 911,647 | 308,717 | (94,000) | 1,126,364 |
| 17,319,378 | (17,636) | (94,000) | 17,207,742 |
| Net current | ||||||
|---|---|---|---|---|---|---|
| assets/ | Non-current | |||||
| Fixed assets | (liabilities) | liabilities | Total | |||
2020 |
2020 |
2020 |
2020 |
|||
| £ | £ | £ | £ | |||
| Expendable | endowment | funds | 13,722,255 | (476,451) | - | 13,245,804 |
| Unrestricted | distribution | funds | 801,867 | 461,221 | (185,116) | 1,077,972 |
| 14,524,122 | (15,230) | (185,116) | 14,323,776 |
2021 |
2020 |
|
|---|---|---|
£ |
£ |
|
| Net income/(expenditure) forthe year (as perthe | 2,883,966 | (727,028) |
| statement offinancial activities) | ||
| Adjustments for: | ||
| Dividends, interest and rents from investments | (616,740) | (616,766) |
| Net realised and unrealised gains/(losses) in the | 2,913,599 | (759,857) |
| year | ||
| (646,373) | (583,897) | |
| (lncrease}/decrease in debtors | (4,682) | |
| (Decrease)/ Increase in creditors | (137,930) | 326,499 |
| Net cash used in operating activities | (788,985) | (257,398) |
| 1 April 2020 | Cash flows | 31 March 2021 | ||
|---|---|---|---|---|
| £ | £ | £ | ||
| Cash | at bank and in hand | 1,333 | 12,105 | 13,438 |
| Cash | held by investment managers | 133,236 | (66,007) | 67,229 |
| 134,569 | (53,902) | 80,667 |